Physician profile
Gordon Ho
NPI 1346516069
$16,387.47
in general payments reported to CMS, 2019-2025
22 companies · $4,437 in 2025
The $4,437 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $60.62 · 2021: $230 · 2022: $1,105 · 2023: $4,225 · 2024: $5,534 · 2025: $4,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,550 · Food and Beverage: $3,844 · Consulting Fee: $2,475 · Travel and Lodging: $2,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,550.00 |
| Food and Beverage | $3,844.11 |
| Consulting Fee | $2,475.00 |
| Travel and Lodging | $2,326.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,803.63 | 2022-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Biotronik INC. | $4,690.69 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Selectra |
| Kestra Medical Technology Services, INC. | $2,463.23 | 2022-2023 | Assure Wcd |
| Abbott Laboratories | $1,958.07 | 2019-2025 | Confirm Rx, Tacticath Ablation Catheter, Sensor Enabled, Aveir |
| Stereotaxis INC | $486.44 | 2023 | Niobe |
| Biosense Webster, INC. | $479.64 | 2019-2023 | Nuvision Ice Catheter, Octaray Mapping Catheter, Carto 3 |
| Philips North America LLC | $433.56 | 2021-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5044) Mcot |
| Impulse Dynamics (USA) INC. | $177.59 | 2023 | Optimizer |
| Cardiva Medical, INC. | $173.33 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $147.74 | 2019-2024 | |
| Stryker Corporation | $129.14 | 2024-2025 | N/A |
| Acutus Medical, INC. | $126.81 | 2023 | |
| Viz.Ai, INC. | $104.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $67.20 | 2024 | |
| Alnylam Pharmaceuticals INC. | $30.35 | 2025 | Amvuttra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $29.78 | 2019 | |
| Scpharmaceuticals INC. | $21.21 | 2023 | |
| Amgen INC. | $19.40 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $18.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.55 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.62 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$102,900.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.